These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 16173922)

  • 21. A novel LZAP-binding protein, NLBP, inhibits cell invasion.
    Kwon J; Cho HJ; Han SH; No JG; Kwon JY; Kim H
    J Biol Chem; 2010 Apr; 285(16):12232-40. PubMed ID: 20164180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways.
    Zhang Y; Xiong Y; Yarbrough WG
    Cell; 1998 Mar; 92(6):725-34. PubMed ID: 9529249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abundant expression of spliced HDM2 in Hodgkin lymphoma cells does not interfere with p14(ARF) and p53 binding.
    Stürzenhofecker B; Schlott T; Quentin T; Kube D; Jung W; Trümper L
    Leuk Lymphoma; 2003 Sep; 44(9):1587-96. PubMed ID: 14565663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CARF (collaborator of ARF) interacts with HDM2: evidence for a novel regulatory feedback regulation of CARF-p53-HDM2-p21WAF1 pathway.
    Hasan MK; Yaguchi T; Harada JI; Hirano T; Wadhwa R; Kaul SC
    Int J Oncol; 2008 Mar; 32(3):663-71. PubMed ID: 18292944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ARF impedes NPM/B23 shuttling in an Mdm2-sensitive tumor suppressor pathway.
    Brady SN; Yu Y; Maggi LB; Weber JD
    Mol Cell Biol; 2004 Nov; 24(21):9327-38. PubMed ID: 15485902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The ARF tumour suppressor.
    Gallagher SJ; Kefford RF; Rizos H
    Int J Biochem Cell Biol; 2006; 38(10):1637-41. PubMed ID: 16600663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AKT regulates NPM dependent ARF localization and p53mut stability in tumors.
    Hamilton G; Abraham AG; Morton J; Sampson O; Pefani DE; Khoronenkova S; Grawenda A; Papaspyropoulos A; Jamieson N; McKay C; Sansom O; Dianov GL; O'Neill E
    Oncotarget; 2014 Aug; 5(15):6142-67. PubMed ID: 25071014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cooperative signals governing ARF-mdm2 interaction and nucleolar localization of the complex.
    Weber JD; Kuo ML; Bothner B; DiGiammarino EL; Kriwacki RW; Roussel MF; Sherr CJ
    Mol Cell Biol; 2000 Apr; 20(7):2517-28. PubMed ID: 10713175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p53-Dependent and -independent functions of the Arf tumor suppressor.
    Sherr CJ; Bertwistle D; DEN Besten W; Kuo ML; Sugimoto M; Tago K; Williams RT; Zindy F; Roussel MF
    Cold Spring Harb Symp Quant Biol; 2005; 70():129-37. PubMed ID: 16869746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrinsically unstructured domains of Arf and Hdm2 form bimolecular oligomeric structures in vitro and in vivo.
    Sivakolundu SG; Nourse A; Moshiach S; Bothner B; Ashley C; Satumba J; Lahti J; Kriwacki RW
    J Mol Biol; 2008 Dec; 384(1):240-54. PubMed ID: 18809412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Azidothymidine and cisplatin increase p14ARF expression in OVCAR-3 ovarian cancer cell line.
    Vaskivuo L; Rysä J; Koivuperä J; Myllynen P; Vaskivuo T; Chvalova K; Serpi R; Savolainen ER; Puistola U; Vähäkangas K
    Toxicol Appl Pharmacol; 2006 Oct; 216(1):89-97. PubMed ID: 16797627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p14(ARF) inhibits the functions of adenovirus E1A oncoprotein.
    Shen J; Zhang S; Li Y; Zhang W; Chen J; Zhang M; Wang T; Jiang L; Zou X; Wong J; Li X; Cui Y; Wang C
    Biochem J; 2011 Mar; 434(2):275-85. PubMed ID: 21133853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expression of proteins in p53 (p14ARF-mdm2-p53-p21WAF/CIP1) pathway and their significance in exocrine pancreatic carcinoma].
    Yu GZ; Zhu MH; Ni CR; Li FM; Zheng JM; Gong ZJ
    Zhonghua Bing Li Xue Za Zhi; 2004 Apr; 33(2):130-4. PubMed ID: 15132849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth suppression by a p14(ARF) exon 1beta adenovirus in human tumor cell lines of varying p53 and Rb status.
    Saadatmandi N; Tyler T; Huang Y; Haghighi A; Frost G; Borgstrom P; Gjerset RA
    Cancer Gene Ther; 2002 Oct; 9(10):830-9. PubMed ID: 12224024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p19(ARF) is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumor suppression in vivo.
    Tolbert D; Lu X; Yin C; Tantama M; Van Dyke T
    Mol Cell Biol; 2002 Jan; 22(1):370-7. PubMed ID: 11739748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2.
    Kamijo T; Weber JD; Zambetti G; Zindy F; Roussel MF; Sherr CJ
    Proc Natl Acad Sci U S A; 1998 Jul; 95(14):8292-7. PubMed ID: 9653180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamics in the p53-Mdm2 ubiquitination pathway.
    Brooks CL; Gu W
    Cell Cycle; 2004 Jul; 3(7):895-9. PubMed ID: 15254415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormal MDMX degradation in tumor cells due to ARF deficiency.
    Li X; Gilkes D; Li B; Cheng Q; Pernazza D; Lawrence H; Lawrence N; Chen J
    Oncogene; 2012 Aug; 31(32):3721-32. PubMed ID: 22120712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p14ARF regulates E2F-1 ubiquitination and degradation via a p53-dependent mechanism.
    Rizos H; Scurr LL; Irvine M; Alling NJ; Kefford RF
    Cell Cycle; 2007 Jul; 6(14):1741-7. PubMed ID: 17630509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MdmX binding to ARF affects Mdm2 protein stability and p53 transactivation.
    Jackson MW; Lindstrom MS; Berberich SJ
    J Biol Chem; 2001 Jul; 276(27):25336-41. PubMed ID: 11297540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.